The improving environment for deals is encouraging some smaller firms to start hunting much larger prey.Most Read from BloombergManhattan’s Morning Commute Time Drops With New Congestion TollHow the ...
Defense secretary addresses nation as 67 passengers feared dead after American Airlines jet collides with military helicopter - ...
Goldman Sachs analyst Matthew Sykes double downgraded Cytek Biosciences (CTKB) to Sell from Buy with a price target of $4.50, down from $7. The ...
In a regulatory filing, Adobe (ADBE) disclosed that on January 24, Scott Belsky notified the company of his decision to resign as Chief ...
AT&T Inc. Dep. Pfd. (Rep. 1/1000th 4.75% Pfd. Series C) 0.77% AT&T Inc. Dep. Pfd. (Rep. 1/1000th 5% Perp. Pfd. Series A) 0.00% ...
Inovio Pharmaceuticals Inc. 2.96% $73.28M ...